Skip to content
Trial Eligibility
Menu

Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining

NCT00242723

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Background: Chromatin is is the structural building block of a chromosome. It is found inside the nucleus of the cell and consists of a complex of DNA and protein. Cancers of the lung, pleura (lung lining) and esophagus show profound changes in chromatin structure that may affect the course of disease in participants. A better understanding of these diseases and the genetic changes associated with them may be helpful in developing new treatments for them.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Thoracic Cancers
  • Malignant Pleural Mesotheliomas NOS
  • Lung Cancer NOS
  • Esophageal Cancers NOS
  • Cancers of Non Thoracic Origin With Metastases to the Lungs or Pleura
  • Thoracic Malignancies

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
2 to 120 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
National Cancer Institute (NCI)
Last updated on ClinicalTrials.gov
October 15, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • National Institutes of Health Clinical Center · Bethesda, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.